$40.57
1.25% yesterday
NYSE, Dec 08, 10:14 pm CET

Conmed Corp. Stock price

$40.57
-3.38 7.69% 1M
-18.47 31.28% 6M
-27.87 40.72% YTD
-34.12 45.68% 1Y
-49.31 54.86% 3Y
-61.34 60.19% 5Y
-1.78 4.20% 10Y
+16.80 70.68% 20Y
NYSE, Closing price Mon, Dec 08 2025
+0.50 1.25%

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$2.1b
Net debt
$814.8m
Cash
$38.9m
Shares outstanding
31.0m
Valuation (TTM | estimate)
P/E
19.7 | 8.8
P/S
0.9 | 0.9
EV/Sales
1.5 | 1.5
EV/FCF
13.9
P/B
1.3
Dividends
DPS
$0.80
Yield 1Y | 5Y
2.0% | 0.8%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
18.8% | 66.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.3b | $1.4b
EBITDA
$152.8m | $290.8m
EBIT
$118.0m | $213.9m
Net Income
$64.3m | $142.2m
Free Cash Flow
$148.7m
Growth (TTM | estimate)
Revenue
4.6% | 6.7%
EBITDA
-37.1% | 19.2%
EBIT
-43.2% | 2.2%
Net Income
-51.2% | 7.4%
Free Cash Flow
-10.7%
Margin (TTM | estimate)
Gross
54.2%
EBITDA
11.3% | 20.8%
EBIT
8.8%
Net
4.8% | 10.2%
Free Cash Flow
11.0%
Financial Health
Equity Ratio
41.7%
Return on Equity
13.8%
ROCE
5.9%
ROIC
4.3%
Debt/Equity
0.8
More
EPS
$2.1
FCF per Share
$4.8
Short interest
9.9%
Employees
4k
Rev per Employee
$340.0k
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Conmed Corp. forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a Conmed Corp. forecast:

Buy
50%
Hold
50%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,347 1,347
5% 5%
100%
- Direct Costs 617 617
8% 8%
46%
731 731
2% 2%
54%
- Selling and Administrative Expenses 523 523
22% 22%
39%
- Research and Development Expense 54 54
2% 2%
4%
153 153
37% 37%
11%
- Depreciation and Amortization 35 35
0% 0%
3%
EBIT (Operating Income) EBIT 118 118
43% 43%
9%
Net Profit 64 64
51% 51%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Business Wire
4 days ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align operations and resources within its core markets—minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, and the surgical treatment of orthopedic soft...
Neutral
Seeking Alpha
about one month ago
CONMED Corporation ( CNMD ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Patrick Beyer - President, CEO & Director Todd Garner - Executive VP of Finance & CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Anna Runci - Piper Sandler & Co., Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Yo...
Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Sales of $337.9 million increased 6.7% year-over-year as reported and 6.3% in constant currency. Domestic revenue increased 5.9% year-over-year. International revenue increased 7.8% year-over-year as reported and 6.8% in co...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 3,900
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today